AGIO
Price
$42.54
Change
-$1.09 (-2.50%)
Updated
Nov 13 closing price
Capitalization
2.48B
90 days until earnings call
Intraday BUY SELL Signals
BLTE
Price
$112.41
Change
+$1.59 (+1.43%)
Updated
Nov 13 closing price
Capitalization
3.94B
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AGIO vs BLTE

Header iconAGIO vs BLTE Comparison
Open Charts AGIO vs BLTEBanner chart's image
Agios Pharmaceuticals
Price$42.54
Change-$1.09 (-2.50%)
Volume$666.85K
Capitalization2.48B
Belite Bio
Price$112.41
Change+$1.59 (+1.43%)
Volume$45.24K
Capitalization3.94B
AGIO vs BLTE Comparison Chart in %
AGIO
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AGIO vs. BLTE commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and BLTE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AGIO: $42.54 vs. BLTE: $112.41)
Brand notoriety: AGIO and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 118% vs. BLTE: 58%
Market capitalization -- AGIO: $2.48B vs. BLTE: $3.94B
AGIO [@Biotechnology] is valued at $2.48B. BLTE’s [@Biotechnology] market capitalization is $3.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while BLTE’s TA Score has 2 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 4 bearish.
  • BLTE’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than BLTE.

Price Growth

AGIO (@Biotechnology) experienced а +5.53% price change this week, while BLTE (@Biotechnology) price change was +0.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 12, 2026.

BLTE is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($3.94B) has a higher market cap than AGIO($2.48B). BLTE YTD gains are higher at: 78.146 vs. AGIO (29.458). BLTE has higher annual earnings (EBITDA): -50.43M vs. AGIO (-456.28M). AGIO has higher revenues than BLTE: AGIO (40.9M) vs BLTE (0).
AGIOBLTEAGIO / BLTE
Capitalization2.48B3.94B63%
EBITDA-456.28M-50.43M905%
Gain YTD29.45878.14638%
P/E Ratio3.82N/A-
Revenue40.9M0-
Total Cash939MN/A-
Total Debt48.8MN/A-
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOBLTE
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PZISX12.99-0.02
-0.15%
Pzena Small Cap Value Institutional
HFYYX13.79-0.07
-0.51%
Hartford Schroders Intl Multi-Cp Val Y
TINCX2.85-0.02
-0.70%
Templeton Global Dynamic Income A1
HDGSX38.62-0.42
-1.08%
Hartford Dividend and Growth R4
MWOCX50.44-0.73
-1.43%
MFS Global Growth C

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with VRDN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-2.50%
VRDN - AGIO
51%
Loosely correlated
-1.55%
LGND - AGIO
47%
Loosely correlated
-2.11%
ELVN - AGIO
46%
Loosely correlated
-0.15%
SYRE - AGIO
46%
Loosely correlated
-3.41%
CRNX - AGIO
46%
Loosely correlated
-3.25%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+1.44%
RAIN - BLTE
48%
Loosely correlated
+6.10%
ACOG - BLTE
26%
Poorly correlated
+0.16%
ROIV - BLTE
23%
Poorly correlated
-3.56%
AGIO - BLTE
22%
Poorly correlated
-2.50%
APLS - BLTE
22%
Poorly correlated
-1.05%
More